-
Information-Publications
-
Brown-fat-mediated tumour suppression by cold-altered global metabolismDetails
-
A Pathogenic Role for FcγRI in the Immune Response against Chlamydial Respiratory InfectionDetails
-
Investigation on the Pathological Mechanism of Frequent Exacerbators With Chronic Obstructive Pulmonary Disease Based on the Characteristics of Respiratory FloraDetails
-
Effect of dermatopontin on osteogenic differentiation of periodontal ligament stem cellsDetails
-
A novel mutation located in the intermembrane space domain of AFG3L2 causes dominant optic atrophy through decreasing the stability of the encoded …Details
-
Additional mutations based on Omicron BA. 2.75 mediate its further evasion from broadly neutralizing antibodiesDetails
-
"Heyuan Liji" is a joint venture between Heyuan Biotechnology (stock code: 688238) and Liji Biotechnology, specializing in the "Liji Biotechnology" and "Life-ilab" reagent brands